{
  "ptid_time": "099_S_0352_2011-04-04",
  "img_path": "/data/qiuhui/data/adni/images/099_S_0352/2011-04-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 48,526 mm³, 31.3% above the reference mean. With a Z-score of 0.84 (80.1th percentile), this represents normal volume ; hippocampal volume measures 4,828 mm³, 25.7% below the reference mean. With a Z-score of -2.06 (2.0th percentile), this represents significant atrophy; whole brain volume measures 755,969 mm³, 18.6% below the reference mean. With a Z-score of -2.23 (1.3th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,563 mm³, 26.0% below the reference mean. With a Z-score of -1.40 (8.0th percentile), this represents mild atrophy; fusiform gyrus volume measures 14,186 mm³, 11.9% below the reference mean. With a Z-score of -0.90 (18.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 14,374 mm³, 20.3% below the reference mean. With a Z-score of -1.80 (3.6th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 82.0 years. Gender is Female. Education: 14 years. Handedness: Right. Race: White. MMSE: 30.0. MoCA: 25.0. Logical Memory: 17.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.87 SUVR (moderate reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "Reasoning: The imaging data shows significant atrophy in the hippocampus and whole brain volume, along with moderate atrophy in the middle temporal gyrus, which are key regions affected in Alzheimer's disease. Despite normal cognitive screening scores (MMSE 30, MoCA 25), the structural changes suggest neurodegeneration. The absence of APOE4 and moderate AV45 (amyloid) reduction may indicate a non-amyloid pathology or early-stage changes.  \nDiagnosis: **MCI** (Mild Cognitive Impairment)  \nConfidence: **Medium** (due to conflicting biomarkers and high cognitive scores despite atrophy)",
  "timestamp": "2025-07-26T10:55:23.847067"
}